Skip to content

A clinical research of high-sensitivity C-reactive protein combined with low-density lipoprotein cholesterol as the dual target of statin therapy

A clinical research of high-sensitivity C-reactive protein combined with low-density lipoprotein cholesterol as the dual target of statin therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-PNR-16007706
Enrollment
Unknown
Registered
2015-12-18
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome

Interventions

A group:atorvastatin 40mg/d for 1 month and then with atorvastatin 20mg/d to maintain until LDL-C<2.07mmol/L
B group:atorvastatin 40mg/d for 1 month and then with atorvastatin 20mg/d to maintain until LDL-C<2.07mmol/L and hs-CRP<3mg/L

Sponsors

Pudong New Area District Zhoupu Hospital, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
38 Years to 86 Years

Inclusion criteria

Inclusion criteria: (1) Unstable Angina: The new onset or the worse angina over the previous 1 month at the time of presentation coinciding with appropriate objective evidence of myocardial ischemia in ECG or myocardial perfusion imaging. At least 1 de novo lesion with >50% stenosis was founded by coronary angiography (CAG); (2) Acute Myocardial Infarction: The chest pain lasted more than 30 minutes and the levels of troponin-T and creatine kinase muscle B (CK-MB) was more than 3 times the upper limit of normal with or without ST-segment elevation. Plaque rupture and thrombosis were confirmed by CAG.

Exclusion criteria

Exclusion criteria: (1) Previous myocardial infarction; (2) Previous stroke; (3) Previous revascularization; (4) Hepatic dysfunction or renal dysfunction; (5) Complicated with malignant tumor or severe organ failure.

Design outcomes

Primary

MeasureTime frame
high-sensitivity C-reactive protein, hs-CRP;low-density lipoprotein cholesterol, LDL-C;

Secondary

MeasureTime frame
Alanine aminotransferase, ALT;cardiac troponin I, cTnI;creatinine kinase, MB isoenzyme, CK-MB;creatinine kinase, CK;Myoglobin, Mb;serum creatinine;electrocardiogram, ECG;Percentage of coronary artery stenosis;

Countries

China

Contacts

Public ContactFANG Ming
fangmingxl@sina.com+86 13307607316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026